Apply before February 20!

Researchers at the Max Delbrück Center have developed a fast, cost-effective blood-based tool that can identify and classify immune deficiencies with high accuracy. The approach, published in “Nature Communications,” could help address long-standing…

Medication errors represent one of the most underestimated risks in professional care. In Germany alone, an estimated 250,000 hospital admissions occur annually due to incorrect medication, resulting in costs of up to €1 billion per year. Behind…

Dr. Sievert Weiss is a physician, co-founder, and medical director of AMBOSS. Since its founding, he and an interdisciplinary team have pursued the goal of making medical knowledge available where it is needed in everyday clinical practice.

For more than 20 years, JPT Peptide Technologies has been producing peptides for scientific purposes and the pharmaceutical industry in Berlin. In the year 2009, the biotech company was acquired by Mainz-based BioNTech SE and has since grown…

In the study, [68Ga]Ga-Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral aldosterone-producing adenomas compared with adrenal vein sampling (AVS) and surgical outcomes

The…

Apply now until April 15, 2026!

Europe's leading digital health platform closes Series D round to expand access to chronic care, led by long-term, impact-focused healthcare investors.

Apply now!

The appliedAI Institute for Europe gGmbH is inviting AI startups to take part in the German AI Startup Landscape 2026 – an annual overview that helps make the diversity of Germany’s AI ecosystem visible.